Indian Pharma Stocks Surge on US Price Order

  Published 10 months ago

Indian pharmaceutical stocks rallied after the US HHS announced it expects branded drugmakers to align US prices with peer nations. Analysts believe this benefits generic and biosimilar companies, reversing a previous dip caused by Trump's price-cut order.

  • NIPHARM index climbed 1.7%, leading sectors.
  • Gland Pharma jumped 4%, leading stock gains.
  • Generic/biosimilar firms see 'big relief'.

You might like these

MSCI Adds 4 Indian Stocks, $1B Inflows

Adani Denies U.S. Bribery Allegations Affirms Clean Record

Entero Healthcare Shares Fall on Downgrade

Google Hires Windsurf AI Talent

India's Grid Upgrade: Hitachi's 765kV Transformers Drive Growth

Bharat Electronics Gains on Missile Deal

Max Estates & ASLL Senior Living Partnership

News that matters the most ⚡